Pfizer-Wyeth Focuses On Whether To Retain Healthcare And OTC Products
This article was originally published in PharmAsia News
Executive Summary
With Pfizer's rapid integration of its recently acquired Wyeth Pharmaceuticals, the focus of attention shifts to whether it will retain Wyeth's healthcare and OTC products